InvestorsHub Logo
Boards
News
Market Data
Markets
Discover
Discover
Subscribe Login/Register
S&P 500
5,127.79
(
1.26%
)
US TECH 100
17,446.00
(
2.17%
)
Dow Jones
38,675.68
(
1.18%
)
Brent Oil
83.10
(
-0.04%
)
Bitcoin
64,216.56
(
0.34%
)
Post# of 14671
Next 10
Reply Private New
Public Reply Private Reply New Post
Keep Last Read
Keep Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

NoMoDo

Send PM Follow Ignore
Followers 148
Posts 7871
Boards Moderated 2
Alias Born 03/15/2002

NoMoDo

Member Level

Re: None

Monday, 03/18/2002 12:09:59 PM

Monday, March 18, 2002 12:09:59 PM

Post# of 14671
News, I mean PR... Thank you tim....

BioShield Technologies, Inc.'s Chairman Issues Letter to Shareholders and



RELATED SYMBOLS: (BSTI)

ATLANTA, Mar 18, 2002 /PRNewswire-FirstCall via COMTEX/ -- BioShield
Technologies, Inc.'s (OTC Bulletin Board: BSTI) chairman has issued the
following letter to all shareholders:

Dear BioShield Shareholders and potential investors,

At BioShield, we seek the highest return on all our initiatives. Today, as we
transition BioShield to a new age, we are making great strides towards
profitability. Consistent growth and our relationship with our shareholders and
clients is the next critical measure of success. Our goal is to be one of the
world's leading suppliers and licensors of antimicrobial and new combined
antibiotic products to help promote a safer, healthier lifestyle and
environmentally friendly planet. Meeting these goals is a serious challenge that
we are committed to, and something that we would like to share with you in
greater detail.

BIOSHIELD -- THE ANTIMICROBIAL COMPANY

We enjoy an excellent reputation for delivering new products that far exceed the
effectiveness, durability and environmental friendliness than that of our
existing competitors. The restructuring of BioShield operations and new focus on
becoming a wholesaler and licensor of our antimicrobial/antibacterial products
has taken significant expense, commitment, time, and effort to establish the
foundation that we are now sitting on. We have come a long way during the past
year; however, there is still considerable work to be done and many more
objectives to be met. Our revenues have increased 100% year over year (based
upon 12.31.01), we have eliminated over $5 million in liabilities, we've
successfully achieved our cost cutting measures reaching our first profitable
quarter, excluding extraordinary items, and we have established several new
global, national, and specialty licensee partners and clients representing over
$55 million in committed long-term and short-term purchase agreements
encompassing the next six years. We have five additional long-term, and many
specialty, purchase agreements under negotiation at this time; however, it is
extremely difficult to project quarterly order flow as the long term purchase
commitment contracts require considerable marketing efforts and time to fully
implement their strategies.

BIOSHIELD'S NEW FOUNDATION

One of the major cornerstones of BioShield's long-standing potential and growth
prospects is our line of patented and EPA registered products. BioShield's core
technology was founded upon antimicrobial technology that had been developed by
Dow Corning 20 years ago after $25 million had been invested in research and
development. As Dow Corning was unable to achieve the effectiveness of killing
bacteria, molds, mildew, etc. in a water based, non- toxic fashion, the project
was finally scrapped. Dow moved on to other ventures. Co-founder, Jacques
Elfersy, and I seized the opportunity to modify and re-engineer this technology,
and thus BioShield Technologies was born. We then applied for new patents and
EPA registrations under the BioShield name. The past seven years have been spent
developing and perfecting this antimicrobial technology. Approximately $20
million was raised for R&D, multiple patent applications, testing and EPA
registrations. Our products have reached a point where they have become known by
some of the world's largest chemical companies as the next killer chemical to
hit the marketplace. These companies have recognized that our technology can
revolutionize the industry of antimicrobials and biocides with significant
opportunities to impact other industries such as specialty chemicals, coatings,
polymers, pulp & paper, and biological warfare. The vast experience of
management coupled with the achievements we've made with new existing client
relationships and potential partners that we are currently in negotiation with,
provides us with a very high degree of confidence that BioShield will be able to
capitalize on these opportunities and become a globally recognized company
during the next couple of years.

Part of establishing ourselves as an industry leader and building upon our new
foundation is our ability to focus on our current operating philosophy of
building partner/licensee relationships, cost competitiveness and high quality
and customer responsiveness. As we pursue these new opportunities and enhance
our distribution and licensing business models, we will be embracing information
technologies that will help us get there. When properly implemented, this
information technology infrastructure will allow us to not only confirm our
existing philosophy but also will allow us to rise above the competition in
delivering lower cost solutions with the highest quality products. We also are
striving to provide unparalleled responsiveness in customer dealings and
adaptation to a full range of business dynamics and developments within our
industry. I have directed that BioShield move with speed to employ the Internet
and selected e-business tools to automate our customer and supplier transactions
so as to truly change the way business is conducted between BioShield and our
partners. In today's business climate, BioShield is becoming digitized and
Web-enabled, which also connotes being innovative, progressive, energized,
motivated, enlightened, focused and much more. We are fully committed to
BioShield, our loyal shareholders, and letting the world know about our
technology. We invite you to visit our new website at www.bioshield.com .

OPPORTUNITIES FOR THE FUTURE

BioShield's future outlook is extremely favorable. The world market for
antimicrobials and biocides is projected to reach approximately $6 billion by
2004 with North America and Western Europe as the largest regional markets
accounting for approximately 70% of the demand. Additionally, we recently formed
a new subsidiary, Nova BioGenetics, to capitalize on the FDA applications within
our technology window and research capabilities; and as the public and regional
governments continue to voice their concern over environmental impacts and the
toxicities of existing antimicrobial, biocide and antibiotic compounds, we
intend to listen and provide the solutions to these concerns and problems.
BioShield's technologies can easily become and intends to become the industry's
leader. We strongly believe that BioShield has the organization, management,
customers, abilities, employees, and supplier partnerships to capitalize on
these trends and many other available opportunities, but we will need to work
diligently to aggressively implement such a demanding need for BioShield to
become recognized and reliable. We are very optimistic as we look to fiscal 2003
and beyond, and believe that, having a superior product line and a complete
research pipeline, we are well positioned for sustained long-term growth.

As always, we are most appreciative of our loyal shareholders, the contributions
of our employees and directors, and the support of our customers and suppliers.
It is teamwork among all these constituencies that ultimately benefits the value
of our company and assures the continued success of BioShield.


Sincerely,
Timothy C. Moses
Chairman/CEO

Further information on BioShield and its line of products can be found by
visiting the firm's web site at http://www.bioshield.com or by calling
1-770-925-3653, Tim Moses.

Public Reply Private Reply New Post
Keep Last Read
Keep Last Read Next 10 Report Keyboard Shortcuts
Next 10 Prev Next

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.

Sign Up